Arthur Herring, Author at Zaman

Is Johnson & Johnson’s Stock a Hidden Gem Amid Legal Turmoil?

Johnson & Johnson (JNJ) holds a strong position in healthcare with over 10 blockbuster drugs. The company is known for its stability, benefiting from consistent pharmaceutical sales regardless of economic conditions. Strategic spin-off of the consumer health division is expected to enhance

2 February 2025

*DE·*FR·Action·Crypto·News·PC·Rigetti Computing·YouTube

Unleash Your Investment Potential: These Stocks Are Shaking Things Up

The Nasdaq and S&P 500 experienced declines of 1.6% and 1%, respectively, while the Dow saw a slight increase of 0.3%. New tariffs of up to 25% on imports from China, Mexico, and Canada were announced, increasing market volatility. Rigetti Computing’s stock

2 February 2025

*DE·Action·Advanced Micro Devices·AMD·Jim Cramer·News·NVIDIA·Oil·PC·Semiconductor Industry

Jim Cramer’s AI Insights: Is AMD Set to Rise or Fall Amidst GPU Concerns?

The AI landscape is evolving, influencing market dynamics and investor expectations. Recent advancements in AI models have created uncertainty, leading to significant drops in data center stock values. AMD has performed relatively better than others, with a loss of only 6.4% during

1 February 2025

News·YouTube

Discover Why Dividend Stocks Are Making a Bold Comeback

Dividend stocks are regaining popularity as interest rates decrease, presenting a lucrative investment option. They provide a steady income stream alongside potential capital growth, appealing to income-conscious investors. The shift away from tech stocks highlights the importance of stable, income-generating investments. Adaptability

31 January 2025

*DE·News·PC

Pharmamar’s Stock Soars: Is a Game-Changer on the Horizon?

Pharmamar’s stock has increased over 12% recently, reaching 83 euros. The company is nearing a significant resistance point, having struggled to break it since October. Strong financial outcomes in the U.S. pharma sector have made it attractive to investors. Experts suggest that

31 January 2025

*DE·Intel·News

Unlocking Europe’s AI Goldmine: Is Merck KGaA Worth Your Investment?

Investment interest in European AI stocks is growing again, with significant returns since early 2023. Merck KGaA is highlighted as a key player amidst the AI surge, with analysts optimistic about its growth prospects. AI stocks have outperformed benchmarks like the MSCI

31 January 2025

News·PC·YouTube

Zaccharie Risacher’s Epic Comeback Sparks Hope for the Hawks

Zaccharie Risacher returned to the NBA after a two-week injury layoff, energizing Hawks fans during a challenging losing streak. In his comeback game, Risacher recorded 11 points, 7 rebounds, and 3 assists against the Minnesota Timberwolves. Despite the loss, his lively playing

31 January 2025

*DE·Intel·News·Oil·xCS·YouTube

Unlock Hidden Wealth: Top Dividend Stocks to Boost Your Income

Dividend stocks are gaining popularity among investors seeking stability and income in fluctuating markets. Key players include Tsubakimoto Chain (4.18%), Guaranty Trust Holding (5.94%), and Padma Oil (7.45%), highlighting attractive dividend yields. Investors should be cautious, as solid dividends can sometimes mask

31 January 2025

*FR·Action·Apple·Electric Vehicles·News·Paramount

Bangkok’s Bold Move: Free Train and Bus Rides to Combat Toxic Air

Bangkok is offering free train and bus rides from January 25 to 31 in response to severe air pollution. PM2.5 pollution levels in the city are significantly exceeding safe limits, prompting urgent action. Construction dust contributes to the worsening air quality, increasing

31 January 2025

*DE·Intel·Meta·News·Release·VR·YouTube

Why Meta Platforms Might Just Be the Goldmine Investors Are Overlooking

Meta’s current trading price is $674.33, with attractive P/E ratios suggesting it may be undervalued. Meta is focusing on AI advancements, particularly through its DeepSeek R1 model and open-sourced Llama models. The potential success of R1 could provide Meta with a significant

29 January 2025